Apidra SoloStar 100 [iU]/mL
insulin glulisine · INJECTION, SOLUTION · sanofi-aventis U.S. LLC
No Recall HistoryCurrently in Shortage
Plain English
Apidra SoloStar is a injection, solution containing insulin glulisine at 100 [iU]/mL, taken subcutaneous. Manufactured by sanofi-aventis U.S. LLC.
Key Facts
- Brand Name
- Apidra SoloStar
- Generic Name
- insulin glulisine
- NDC Code (Product)
0088-2502- Manufacturer
- sanofi-aventis U.S. LLC
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA021629
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 02/24/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is Apidra SoloStar used for?
Apidra SoloStar contains insulin glulisine. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Apidra SoloStar a controlled substance?
Apidra SoloStar is not classified as a controlled substance by the DEA.
What is the generic name for Apidra SoloStar?
The generic name for Apidra SoloStar is insulin glulisine. There are 1 other brand versions of insulin glulisine.
What is the NDC code for Apidra SoloStar 100 [iU]/mL?
The NDC (National Drug Code) for Apidra SoloStar 100 [iU]/mL is 0088-2502, listed by sanofi-aventis U.S. LLC.